COVID-19 has quickly reached pandemic levels since it was first reported in December
2019. The virus responsible for the disease, named SARS-CoV-2, is enveloped positive-…

Introduction: Coronavirus disease 2019 (COVID-19) is still increasing worldwide, and as a
result, the number of patients with pulmonary fibrosis secondary to COVID-19 will expand …

Background: This review article summarizes and updates the knowledge on
paracoccidioidomycosis. P lutzii and the cryptic species of P. brasiliensis and their geographical …

Visceral adiposity is a risk factor for severe COVID-19, and a link between adipose tissue
infection and disease progression has been proposed. Here we demonstrate that SARS-CoV-2 …

Background and Objectives: lung cancer is the leading cause of cancer-related deaths in
the world, and its poor prognosis varies markedly according to tumor staging. Computed …

One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

Background The release of neutrophil extracellular traps (NETs) is associated with inflammation,
coagulopathy, and organ damage found in severe cases of COVID-19. However, the …

Purpose As some of the most important factors for treatment decision of lung cancer (which
is the deadliest neoplasm) are staging and histology, this work aimed to associate …

Background Scientific evidence indicates that endothelial glycocalyx (EG) shedding contributes
to the pathophysiological installation of acute respiratory distress syndrome (ARDS) after …

This brief communication demonstrates the correlation of persistent respiratory symptoms
with functional, tomographic, and transbronchial pulmonary biopsy findings in patients with …